Apigenin Market, By Source, By Form, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Apigenin Market size was valued at US$ 3,720.32 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

Apigenin is a bioactive flavonoid widely found in fruits, vegetables, and herbs, particularly in parsley, celery, and chamomile. It is renowned for its antioxidant, anti-inflammatory, and anti-cancer properties. Structurally belonging to the flavone class, apigenin plays a crucial role in health and wellness industries due to its diverse therapeutic benefits and minimal side effects compared to synthetic drugs. The growing need for apigenin is driven by its significant health benefits. As a potent antioxidant, it neutralizes free radicals, reducing oxidative stress, a key factor in aging and chronic diseases. Its anti-inflammatory effects make it valuable for managing arthritis and cardiovascular disorders. Apigenin is also gaining attention in oncology, where it has demonstrated the ability to induce apoptosis and inhibit tumor growth in cancers such as breast, prostate, and colon. Furthermore, its neuroprotective properties support brain health by promoting neuron formation and reducing the risk of neurodegenerative diseases like Alzheimer's. In the cosmetics industry, apigenin is used for its skin-soothing and anti-aging properties, enhancing product formulations aimed at skin rejuvenation. Additionally, its incorporation into dietary supplements addresses consumer demand for natural health-enhancing ingredients, making it a critical compound in various sectors, from pharmaceuticals to nutraceuticals.

Apigenin Market- Market Dynamics

Increasing demand for natural antioxidants and anti-cancer compounds across pharmaceuticals and nutraceutical industries

Increasing health awareness among consumers has led to a rising preference for plant-based and naturally derived compounds over synthetic alternatives, given their reduced side effects and holistic health benefits. Apigenin, known for its potent antioxidant properties, helps combat oxidative stress, a key factor in chronic conditions such as cardiovascular disease, neurodegenerative disorders, and aging-related issues. Furthermore, its anti-cancer effects-such as inducing apoptosis and inhibiting tumor cell proliferation-make it highly sought after in cancer prevention and treatment research. In nutraceuticals, apigenin is increasingly used in dietary supplements targeting immune support, anti-inflammatory effects, and general wellness, reflecting the growing demand for preventive healthcare solutions. According to a report from the Indian Ministry of AYUSH, the global market for plant-based health products, including natural antioxidants, is experiencing substantial growth due to government-backed initiatives promoting traditional and herbal medicines. This shift aligns with broader health trends favoring natural compounds over synthetic ingredients, highlighting the critical role of apigenin in shaping the future of pharmaceuticals and nutraceuticals. Sustainable sourcing and technological advancements will further enhance its market potential.

Apigenin Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)
Based on Source segmentation, Natural was predicted to show maximum market share in the year 2024
Based on Application segmentation, Food & Beverages was the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024

Apigenin Market- Segmentation Analysis:

The Global Apigenin Market is segmented on the basis of Source, Form, Application, and Region.

The market is divided into two categories based on Source: Natural and Synthetic. Natural dominates the market due to increasing consumer preference for plant-based, eco-friendly products with minimal side effects and proven health benefits. Additionally, regulatory support for organic ingredients further drives demand for naturally sourced compounds like apigenin.

The market is divided into four categories based on Application: Pharmaceuticals, Food & Beverages, Cosmetics & Personal Care, and Dietary Supplements. Food & Beverages dominates the market due to its widespread use as a natural antioxidant and preservative, enhancing product shelf life and nutritional value. Growing consumer demand for functional foods and beverages enriched with health-promoting bioactive compounds further drives its dominance.

Apigenin Market- Geographical Insights

In North America, particularly the United States, there is a growing consumer preference for natural and plant-based ingredients in pharmaceuticals, nutraceuticals, and functional foods, making it one of the leading markets for apigenin. This demand is supported by increasing awareness of the health benefits of antioxidants and anti-cancer compounds. Additionally, the robust regulatory framework and advancements in research contribute to the market's growth in this region. In Europe, the market is expanding due to the rising trend of organic and natural products in food, beverages, and personal care. The European Union's stringent regulations on synthetic chemicals in food and cosmetics have increased the adoption of plant-derived ingredients like apigenin, further fueling market growth. The Asia-Pacific region, especially countries like India and China, is witnessing rapid growth in the apigenin market, driven by a growing shift toward traditional herbal remedies and natural products in health supplements and food. Government initiatives promoting the use of herbal and natural ingredients in healthcare also contribute to the market's expansion in this region.

Apigenin Market- Competitive Landscape:

The Apigenin market is characterized by a competitive landscape with numerous players focused on capitalizing on the increasing demand for natural antioxidants and health-promoting compounds. Key market players adopt various strategies such as product innovation, partnerships, and collaborations to strengthen their market position. Companies are investing in research and development to enhance the bioavailability and effectiveness of apigenin, driving its application across pharmaceuticals, nutraceuticals, and cosmetics. Additionally, the shift towards plant-based and organic ingredients has led to heightened competition among suppliers to source high-quality apigenin from natural and sustainable sources. In terms of market share, the pharmaceutical and nutraceutical sectors are highly competitive, with businesses vying to secure regulatory approvals and develop formulations that appeal to health-conscious consumers. The food and beverages sector also sees competition, with manufacturers incorporating apigenin in functional foods and beverages to cater to the rising demand for antioxidant-rich products. Moreover, the cosmetics industry is increasingly leveraging apigenin for its anti-aging and skin-soothing properties, intensifying competition in the beauty and personal care market. The global nature of the market encourages players to expand their footprint internationally, exploring new regional markets such as Asia-Pacific and Latin America, where consumer demand for natural health solutions is rapidly growing.

Recent Developments:

In May 2024, Tally Health launched its Restore Sleep and Longevity Formula, a blend of ingredients targeting improved sleep and overall longevity. The formula combines several botanicals and nutraceuticals aimed at promoting relaxation and reducing age-related health issues.
In April 2024, 4Life launched Transfer Factor AgePro, a new product combining apigenin with other powerful compounds aimed at enhancing immune support and promoting longevity. This product builds on 4Life's commitment to scientifically backed formulations and proprietary ingredients, including exclusive plant extracts, designed to boost health and wellness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL APIGENIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Monteloeder S.L.
Sigma-Aldrich Corporation
Aksuvital GIda Sanayi ve Ticaret A.S.
Bo International Pvt. Ltd.
Indo Phytochem Pharmaceuticals Pvt. Ltd.
Shaanxi QingLan Bio-Technology Co., Ltd.
Xi'an Incedit Bio-Tech Co., Ltd.
Xi'an Sost Biotech Co., Ltd.
Shaanxi Pioneer Biotech Co., Ltd.
Xi'an Lyphar Biotech Co., Ltd.
Others

GLOBAL APIGENIN MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

Natural
Synthetic

GLOBAL APIGENIN MARKET, BY FORM - MARKET ANALYSIS, 2019 - 2032

Powder
Liquid

GLOBAL APIGENIN MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Pharmaceuticals
Food & Beverages
Cosmetics & Personal Care
Dietary Supplements
Others

GLOBAL APIGENIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4688

1. Apigenin Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Apigenin Market Snippet by Source
- 2.1.2. Apigenin Market Snippet by Form
- 2.1.3. Apigenin Market Snippet by Application
- 2.1.4. Apigenin Market Snippet by Country
- 2.1.5. Apigenin Market Snippet by Region
2.2. Competitive Insights

3. Apigenin Key Market Trends

3.1. Apigenin Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Apigenin Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Apigenin Market Opportunities
3.4. Apigenin Market Future Trends

4. Apigenin Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Apigenin Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Apigenin Market Landscape

6.1. Apigenin Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Apigenin Market - By Source

7.1. Overview
- 7.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
- 7.1.2. Natural
- 7.1.3. Synthetic

8. Apigenin Market - By Form

8.1. Overview
- 8.1.1. Segment Share Analysis, By Form, 2024 & 2032 (%)
- 8.1.2. Powder
- 8.1.3. Liquid

9. Apigenin Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Pharmaceuticals
- 9.1.3. Food & Beverages
- 9.1.4. Cosmetics & Personal Care
- 9.1.5. Dietary Supplements
- 9.1.6. Others

10. Apigenin Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Apigenin Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Apigenin Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Apigenin Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Apigenin Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Apigenin Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Apigenin Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Monteloeder S.L.
- 11.2.2. Sigma-Aldrich Corporation
- 11.2.3. Aksuvital GIda Sanayi ve Ticaret A.S.
- 11.2.4. Bo International Pvt. Ltd.
- 11.2.5. Indo Phytochem Pharmaceuticals Pvt. Ltd.
- 11.2.6. Shaanxi QingLan Bio-Technology Co., Ltd.
- 11.2.7. Xi'an Incedit Bio-Tech Co., Ltd.
- 11.2.8. Xi'an Sost Biotech Co., Ltd.
- 11.2.9. Shaanxi Pioneer Biotech Co., Ltd.
- 11.2.10. Xi'an Lyphar Biotech Co., Ltd.
- 11.2.11. Others

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us